Skip to content

Insider · CIK 0001820885

Susan Bobulsky

officer

Files at ADPT (Adaptive Biotechnologies Corp). First filing Mar 6, 2025, latest Oct 8, 2026.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $407k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

ADPT: Adaptive Biotechnologies Corp

ADPTOct 9, 2026 · close 26.49

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
22Weak
ADPTsell 310b5-1
Adaptive Biotechnologies Corp
$193k
6,444 shares
-2%+117% from low-10% from high
8Weak
ADPTsell 210b5-1
Adaptive Biotechnologies Corp
$32k
1,195 shares
-0%+115% from low0% from high
42Moderate
ADPTsell 10
Adaptive Biotechnologies Corp
$182k
26,023 shares
-7%+101% from low-6% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Oct 6, 2026ADPT
Adaptive Biotechnologies Corp
SOpen-market sale
Common Stock10b5-1
-6,444$30.00$193k389,3504 d ago
Sep 15, 2026ADPT
Adaptive Biotechnologies Corp
SOpen-market sale
Common Stock10b5-1
-1,195$27.00$32k395,79425 d ago
Mar 4, 2025ADPT
Adaptive Biotechnologies Corp
AGrant or award
Common Stock
+119,971$0.00$0373,261Mar 6, 2025
Mar 5, 2025ADPT
Adaptive Biotechnologies Corp
SOpen-market sale
Common Stock
-26,023$6.98$182k347,238Mar 6, 2025
Mar 4, 2025ADPT
Adaptive Biotechnologies Corp
AGrant or award
Stock Option (right to buy)derivative
+180,029$0.00$0180,029Mar 6, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Susan Bobulsky: insider trades and track record | InsiderTell